Skip to main content
Premium Trial:

Request an Annual Quote

Fujifilm, Axcelead Form Drug Discovery Services Alliance

NEW YORK — Fujifilm has partnered with Axcelead Drug Discovery Partners to offer human induced pluripotent stem cell (iPSC)-based drug discovery services, the Japanese companies said today.

Under the terms of the deal, the firms will offer iPCSs and iPCS-derived cells from Fujifilm subsidiary Fujifilm Cellular Dynamics with Axcelead's drug discovery services, as well as customized drug evaluation and toxicity testing methods.

Additional terms were not disclosed.

Fujifilm — which acquired Madison, Wisconsin-based Cellular Dynamics in 2015 — said it will consider further collaborations in the field of drug discovery support by combining culture media and reagents from Fujifilm Irvine Scientific and from Fujifilm Wako Pure Chemical.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.